[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340832-105":59,"doc-detail-340832-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recent-advances-of-engineered-oncolytic-viruses-based-combination-therapy-for-liver-cancer","Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer","","Liver cancer is a major malignant disease that endangers health and increases patients’ economic burden. Gene therapy has been extensively studied, particularly using oncolytic viruses (OVs) engineered to enhance tumor-cell specificity while reducing effects on normal cells. Prior experimental and clinical work suggests OVs can be effective and safe across multiple tumor types. This review summarizes genetically engineered OVs in liver cancer gene therapy, highlights key targets and applications, and analyzes limitations of OV-based combination regimens with proposed solutions to inform future treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recent-advances-of-engineered-oncolytic-viruses-based-combination-therapy-for-liver-cancer/340832/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recent-advances-of-engineered-oncolytic-viruses-based-combination-therapy-for-liver-cancer/340832.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the review on engineered oncolytic viruses for liver cancer?","Question",{"text":112,"@type":113},"It introduces the current status of genetically engineered oncolytic viruses used in gene therapy for liver cancer, focusing on OV applications and target genes, and discusses problems and solutions in OV-based combination therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do engineered oncolytic viruses improve liver cancer treatment?",{"text":117,"@type":113},"Genetic engineering increases OV infection specificity toward tumor cells and reduces impact on normal cells, enabling tumor-specific replication and killing after delivery into the tumor environment.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is selecting an appropriate gene delivery vector important in gene therapy?",{"text":121,"@type":113},"DNA and siRNA can be degraded in vivo, so stable delivery to host cells is required to achieve therapeutic effects and maximize anti-cancer activity while limiting damage to normal tissues and organs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340832,1790211858,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Zhang et al. Journal of Translational Medicine (2024) 22:3  \n[https://doi.org/10.1186/s12967-023-04817-w](https://doi.org/10.1186/s12967-023-04817-w)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nRecent advances of engineered oncolytic viruses-based combination therapy for liver cancer  \nJunhe Zhang1,2,3*† , Yunxi Xiao1†, Jie Zhang3, Yun Yang3, Liao Zhang1 and Fan Liang1  \nAbstract  \nLiver cancer is a major malignant tumor, which seriously threatens human health and increases the economic burden on patients. At present, gene therapy has been comprehensively studied as an excellent therapeutic measure in liver cancer treatment. Oncolytic virus (OV) is a kind of virus that can specifically infect and kill tumor cells. After being modified by genetic engineering, the specificity of OV infection to tumor cells is increased, and its influence on normal cells is reduced. To date, OV has shown its effectiveness and safety in experimental and clinical studies on a variety of tumors. Thus, this review primarily introduces the current status of different genetically engineered OVs used in gene therapy for liver cancer, focuses on the application of OVs and different target genes for current liver cancer therapy, and identifies the problems encountered in OVs-based combination therapy and the corresponding solutions, which will provide new insights into the treatment of liver cancer.  \nKeywords Gene therapy, Liver cancer, Oncolytic virus, Targeted therapy  \nIntroduction  \nLiver cancer is the third leading cause of cancer death worldwide in 2020, with approximately 830,000 deaths [1]. At present, liver cancer is primarily treated with surgical resection and liver transplantation, supplemented by radiotherapy, chemotherapy, targeted therapy and immunotherapy. Although liver resection and liver transplantation are potentially curative, patients must be diagnosed at the earlier stage. Even with strict monitoring, a number of patients with liver cancer are still found in the  \n†Junhe Zhang andYunxi Xiao have contributed equally to this work.  \n*Correspondence: Junhe Zhang [zjh@xxmu.edu.cn](zjh@xxmu.edu.cn)  \n1 Institutes of Health Central Plains, Xinxiang Medical University, No. 601 Jinsui Road, Xinxiang 453003, Henan Province, China  \n2 Henan Key Laboratory of Neurorestoratology, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, China  \n3 School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China  \nmiddle and late stages ofthe tumor, missing the best time for surgery and liver transplantation, which will often cause ineffective treatment [2]. In addition, liver resection and transplantation still face severe damage to liver function and a shortage of liver donors [3]. The lack of specificity of radiotherapy and chemotherapy to tumor cells has extensive side effects. Gene therapy is a biological therapy in which vectors introduce exogenous genes into target cells to alter gene expression, and diseases are corrected or compensated on the basis of genetic defects and abnormalities [4]. Tumor gene therapy still accounts for the majority of global clinical trials, which has achieved major breakthroughs with the advancement of biotechnology. In 1990, gene therapy for adenosine deaminase deficiency was successful. Since then, many clinical programs have been launched worldwide. Gene therapy depends on appropriate gene delivery vectors because deoxyribonucleic acid and small interfering RNA (siRNA) can be easily degraded in vivo, and they must remain stable in host cells to exert therapeutic effects,  \n© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The i","cbCaihQ62umNURhO","https://ap.wps.com/l/cbCaihQ62umNURhO","pdf",1529599,18,"English","# Abstract\n# Introduction\n# Gene therapy and delivery vectors\n# Oncolytic viruses and engineered targeting\n# OV-based combination therapy (overview)","[{\"question\":\"What is the main purpose of the review on engineered oncolytic viruses for liver cancer?\",\"answer\":\"It introduces the current status of genetically engineered oncolytic viruses used in gene therapy for liver cancer, focusing on OV applications and target genes, and discusses problems and solutions in OV-based combination therapy.\"},{\"question\":\"How do engineered oncolytic viruses improve liver cancer treatment?\",\"answer\":\"Genetic engineering increases OV infection specificity toward tumor cells and reduces impact on normal cells, enabling tumor-specific replication and killing after delivery into the tumor environment.\"},{\"question\":\"Why is selecting an appropriate gene delivery vector important in gene therapy?\",\"answer\":\"DNA and siRNA can be degraded in vivo, so stable delivery to host cells is required to achieve therapeutic effects and maximize anti-cancer activity while limiting damage to normal tissues and organs.\"}]","Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer | PDF",1790039078,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3ac842d74c87c7c1da1601792160bfb.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f79660945c7eb1c71205d60d5eef3fee.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8ce3548d0c3ccb0a7d11f9a5e099211.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72a37e5e3b22ea661882e77fc273963e.webp",980,1301]